The Fold Variant BM4 Is Beneficial in a Therapeutic Bet v 1 Mouse Model
Joint Authors
Pichler, Ulrike
Asam, Claudia
Weiss, Richard
Isakovic, Almedina
Hauser, Michael
Briza, Peter
Ferreira, Fatima
Wallner, Michael
Source
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-09-23
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
Specific immunotherapy using recombinant allergens is clinically effective; still wild-type allergens can provoke treatment-induced side effects and often show poor immunogenicity in vivo.
Thus, we tested the low IgE-binding, highly immunogenic fold variant BM4 in a Bet v 1 mouse model.
Methods.
Recombinant BM4 was used as active vaccine ingredient to treat mice sensitized to Bet v 1.
As controls, mice were treated with either Bet v 1 or sham, and the humoral as well as cellular immune response was monitored.
Moreover, lung function and lung inflammation were analysed.
Results.
BM4 was more effective than wild-type Bet v 1 in inducing Bet v 1-specific blocking antibodies as well as IFN-γ and IL-10 producing T cells.
Further, birch pollen induced lung inflammation could be ameliorated significantly by BM4 treatment as demonstrated by a reduction of airway hyperresponsiveness and drastically decreased eosinophil counts in bronchoalveolar lavage fluids.
Conclusion.
The study outlines the high potential of BM4 as vaccine candidate for the treatment of Bet v 1-mediated birch pollen allergies.
American Psychological Association (APA)
Pichler, Ulrike& Asam, Claudia& Weiss, Richard& Isakovic, Almedina& Hauser, Michael& Briza, Peter…[et al.]. 2013. The Fold Variant BM4 Is Beneficial in a Therapeutic Bet v 1 Mouse Model. BioMed Research International،Vol. 2013, no. 2013, pp.1-5.
https://search.emarefa.net/detail/BIM-1005219
Modern Language Association (MLA)
Pichler, Ulrike…[et al.]. The Fold Variant BM4 Is Beneficial in a Therapeutic Bet v 1 Mouse Model. BioMed Research International No. 2013 (2013), pp.1-5.
https://search.emarefa.net/detail/BIM-1005219
American Medical Association (AMA)
Pichler, Ulrike& Asam, Claudia& Weiss, Richard& Isakovic, Almedina& Hauser, Michael& Briza, Peter…[et al.]. The Fold Variant BM4 Is Beneficial in a Therapeutic Bet v 1 Mouse Model. BioMed Research International. 2013. Vol. 2013, no. 2013, pp.1-5.
https://search.emarefa.net/detail/BIM-1005219
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1005219